T1 SUBSTAGE IN NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA CAN PREDICT PROGRESSION FREE SURVIVAL

被引：0
|
作者：
Chen, Yu-Kuang
Lin, Tzu-Ping
Chang, Yen-Hwa
Kuo, Junne-Yih
Chung, Hsiao-Jen
Wu, Howard Hung-Hao
Huang, Eric Yi-Hsiu
Lin, Chih-Chieh
Fan, Yu-Hua
Huang, I-shen
Lu, Shih-Yen
Lin, Alex T. L.
Huang, William J.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP72-04
引用
收藏
页码：E1074 / E1075
页数：2
相关论文
共 50 条
  • [31] Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
    Liedberg, Fredrik
    Kjellstrom, Sofia
    Lind, Anna-Karin
    Sherif, Amir
    Soderkvist, Karin
    Falkman, Karin
    Thulin, Helena
    Aljabery, Firas
    Papantonio, Dimitrious
    Strock, Viveka
    Ofverholm, Elisabeth
    Jerlstrom, Tomas
    Sandzen, Johan
    Verbiene, Ingrida
    Ullen, Anders
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (02) : 137 - 146
  • [32] Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology
    Munari, Enrico
    Calio, Anna
    Brunelli, Matteo
    Martignoni, Guido
    [J]. BJU INTERNATIONAL, 2018, 122 (06) : 914 - 915
  • [33] Metachronous skeletal muscle metastasis from high-grade, non-muscle invasive urothelial carcinoma of the bladder-A peculiar clinical progression
    Lee, G. A.
    Ngoo, K. S.
    [J]. BJU INTERNATIONAL, 2021, 128 : 16 - 16
  • [34] Molecular predictors of non-muscle invasive bladder cancer progression
    Smal, M.
    Rolevich, A.
    Nikitchenko, N.
    Krasny, S.
    Goncharova, R.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 541 - 541
  • [35] NBR1 AND KIF14 ARE THE MTOR PATHWAY DOWNSTREAM TO PREDICT THE RECURRENCE IN NON-MUSCLE INVASIVE LOW GRADE UROTHELIAL CARCINOMA OF THE BLADDER
    Chi, Byung Hoon
    Jin, Subin
    Whang, Young Mi
    Ahn, Seung Hyun
    Choi, Jae Duck
    Lee, Shin Young
    Chang, In Ho
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E570 - E570
  • [36] Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival
    Jimenez, RE
    Gheiler, E
    Oskanian, P
    Tiguert, R
    Sakr, W
    Wood, DP
    Pontes, JE
    Grignon, DJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (07) : 980 - 987
  • [37] Genomic predictors of recurrence (R) or progression (P) in high grade T1 (HGT1) non-muscle invasive (NMI) bladder cancer
    Bellmunt, Joaquim
    Kim, Jaegil
    Mullane, Stephanie A.
    Reardon, Brendan
    Orsola, Anna
    VanAllen, Eliezer
    Getz, Gad
    Kwiatkowski, David J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer
    Muilwijk, Tim
    Akand, Murat
    Daelemans, Sofie
    Marien, Koen
    Waumans, Yannick
    Kockx, Mark
    Baekelandt, Loic
    Van den Broeck, Thomas
    Van der Aa, Frank
    Gevaert, Thomas
    Joniau, Steven
    [J]. PLOS ONE, 2021, 16 (09):
  • [39] A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers
    Pi, Jiangchuan
    Xiong, Yongjiang
    Liu, Chuan
    Liao, Juan
    Liu, Jiaji
    Li, Chuan
    Fu, Wenyu
    Zhao, Tao
    [J]. JOURNAL OF INVESTIGATIVE SURGERY, 2022, 35 (05) : 1186 - 1194
  • [40] The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
    Sikic, Danijel
    Taubert, Helge
    Breyer, Johannes
    Eckstein, Markus
    Weyerer, Veronika
    Keck, Bastian
    Kubon, Jennifer
    Otto, Wolfgang
    Worst, Thomas S.
    Kriegnnair, Maximilian C.
    Erben, Philipp
    Hartmann, Arndt
    Wullich, Bernd
    Wirtz, Ralph M.
    Wach, Sven
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6567 - 6578
12345